Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson's disease
- PMID: 37905853
- PMCID: PMC11467925
- DOI: 10.4103/1673-5374.385862
Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson's disease
Figures
References
-
- Abbott SK, Li H, Munoz SS, Knoch B, Batterham M, Murphy KE, Halliday GM, Garner B. Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease. Mov Disord. (2014);29:518–526. - PubMed
-
- Fridjonsdottir E, Shariatgorji R, Nilsson A, Vallianatou T, Odell LR, Schembri LS, Svenningsson P, Fernagut PO, Crossman AR, Bezard E, Andrén PE. Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia. Sci Adv. (2021);7:eabe5948. - PMC - PubMed
LinkOut - more resources
Full Text Sources
